unbelieveable, page-15

Maldowl
I agree and still continue to accumulate - even on the falling knife! IMO this company has a great future and management are doing an excellent job, but news is generally what adds to the momentum. Until we get more (and I hope it won't be too long - a major licence agreement would be good) the sp will probably languish at its current level.

As with most biotechs, they do need to raise capital from time to time and I wonder whether it's a possibility/probability sooner rather than later. If the price falls too much more (for no good reason other than impatience IMO) one would have to question what price capital would be raised at. In the meantime - happy to pick up more on the dips.